In addition, ICI could be given to patients with lower level of VEGF-A (those of CIN-like group which had higher percentage of PD-L1 positive tumor cells), despite the lack of strong evidence. This evidence concerns the gene VEGFA and cervical squamous intraepithelial neoplasia.